SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.87-2.3%Dec 5 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (2708)1/27/2001 5:26:00 PM
From: Scott H. Davis  Read Replies (1) of 52153
 
Rick, ouch & thanks. You are playing the role I have played professionally for years when unfortunately necessaary needed - the knight of mirrors. I've actually learned (perhaps too little) from listening to you and Miljenko. You both started tossing up red flags about ISIP & it soon tanked, and a lot of upper mgmt spin doctoring was revealed. Stayed away from LGND because of the dilution & spin doctoring and you were a real contributor to that decision. Thanks again. Does not take an incredible IQ to apply you comments to VICL. Guess that means I'll need to re-assess, as while some biotech vets have posted on the thread, I see what you mean about the lack of scientists. I do still appreciate the lack of hype & dilution on the part of VICL mgmt. Perhaps I placed tooo much dependance on the DD of their partners. And as I think about it, while this is a valuation thread, I've looked at the size of the applications for their preventatives, but not on the potential revenue from the partnerships if the vaccines reach commercialization.

So, again, ouch & thanks. Scott

(or I could happily go into denial and assume you were just talking about ISIP & some others;)

In the words of Tom Wait, "the piano has been drinking..."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News